Comment on: Targeting homologous recombination-mediated DNA repair in cancer

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 7, 2014, Pages 833-

  Fiume, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; DNA; GENOTOXIC DRUG; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; DNA REPAIR; GLYCOLYSIS; LETTER; NEOPLASM; PRIMARY TUMOR; ANIMAL; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES; RECOMBINATION REPAIR;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA DAMAGE; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; RECOMBINATIONAL DNA REPAIR;

EID: 84902520257     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.925617     Document Type: Letter

References (5)

1. Carvalho JFS, Kanaar R. Targeting homologous recombination-mediated DNA repair in cancer. Expert Opin Ther Targets 2014;18:427-58
2. Li CY. Inhibitors of DNA repair for cancer therapy, ready for prime time? Transl Cancer Res 2012;1:4-5
3. Fiume L, Manerba M, Vettraino M, et al. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy. Future Med Chem 2014;6:429-45
4. Lans H, Marteijn JA, Vermeulen W. ATPdependent chromatin remodeling in the DNA-damage response. Epigenetics Chromatin 2012;5:4
5. Billiard J, Dennison JB, Briand J, et al. Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metab 2013;1:19